Literature DB >> 14977163

A two-part mixture model for longitudinal adverse event severity data.

Kenneth G Kowalski1, Lynn McFadyen, Matthew M Hutmacher, Bill Frame, Raymond Miller.   

Abstract

We fit a mixed effects logistic regression model to longitudinal adverse event (AE) severity data (four-point ordered categorical response) to describe the dose-AE severity response for an investigational drug. The distribution of the predicted interindividual random effects (Bayes predictions) was extremely bimodal. This extreme bimodality indicated that biased parameter estimates and poor predictive performance were likely. The distribution's primary mode was composed of patients that did not experience an AE. Moreover, the Bayes predictions of these non-AE patients were nearly degenerative, i.e., the predictions were nearly identical. To resolve this extreme bimodality we propose using a two-part mixture modeling approach. The first part models the incidence of AE's, and the second part models the severity grade given the patient had an AE. Unconditional probability predictions are calculated by mixing the incidence and severity model probability predictions. We also report results of simulation studies, which assess the predictive and statistical (bias and precision) performance of our approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14977163     DOI: 10.1023/b:jopa.0000008157.26321.3c

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  8 in total

1.  Maximum likelihood methods for cure rate models with missing covariates.

Authors:  M H Chen; J G Ibrahim
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  A score test for testing a zero-inflated Poisson regression model against zero-inflated negative binomial alternatives.

Authors:  M Ridout; J Hinde; C G Demétrio
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

3.  Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test.

Authors:  K G Kowalski; M M Hutmacher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-06       Impact factor: 2.745

4.  Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data.

Authors:  Gordon Graham; Suneel Gupta; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

5.  Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.

Authors:  S K Gupta; G Sathyan; E A Lindemulder; P L Ho; L B Sheiner; L Aarons
Journal:  Clin Pharmacol Ther       Date:  1999-06       Impact factor: 6.875

6.  The use of mixture models for the analysis of survival data with long-term survivors.

Authors:  V T Farewell
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

7.  Population pharmacodynamic model for ketorolac analgesia.

Authors:  J W Mandema; D R Stanski
Journal:  Clin Pharmacol Ther       Date:  1996-12       Impact factor: 6.875

8.  A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.

Authors:  L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1994-09       Impact factor: 6.875

  8 in total
  14 in total

1.  Pattern Recognition of Longitudinal Trial Data with Nonignorable Missingness: An Empirical Case Study.

Authors:  Hua Fang; Kimberly Andrews Espy; Maria L Rizzo; Christian Stopp; Sandra A Wiebe; Walter W Stroup
Journal:  Int J Inf Technol Decis Mak       Date:  2009-09-01

2.  Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED.

Authors:  Siv Jönsson; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

3.  The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.

Authors:  Maria C Kjellsson; Siv Jönsson; Mats O Karlsson
Journal:  AAPS J       Date:  2004-08-11       Impact factor: 4.009

Review 4.  Conditioning on certain random events associated with statistical variability in PK/PD.

Authors:  Stuart L Beal
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-07       Impact factor: 2.745

5.  Comparison of proportional and differential odds models for mixed-effects analysis of categorical data.

Authors:  Maria C Kjellsson; Per-Henrik Zingmark; E Niclas Jonsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-09-23       Impact factor: 2.745

Review 6.  Pharmacodynamic models for discrete data.

Authors:  Ines Paule; Pascal Girard; Gilles Freyer; Michel Tod
Journal:  Clin Pharmacokinet       Date:  2012-12       Impact factor: 6.447

7.  Hot spots in mortality from drug poisoning in the United States, 2007-2009.

Authors:  Lauren M Rossen; Diba Khan; Margaret Warner
Journal:  Health Place       Date:  2013-12-01       Impact factor: 4.078

8.  Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder.

Authors:  Bill Frame; Raymond Miller; Matthew M Hutmacher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-11-08       Impact factor: 2.745

9.  Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision making.

Authors:  Kristin C Carlsson; Radojka M Savić; Andrew C Hooker; Mats O Karlsson
Journal:  AAPS J       Date:  2009-03-10       Impact factor: 4.009

10.  Trends and geographic patterns in drug-poisoning death rates in the U.S., 1999-2009.

Authors:  Lauren M Rossen; Diba Khan; Margaret Warner
Journal:  Am J Prev Med       Date:  2013-12       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.